Tab. Marlox
Chewable Tablet · PO · 400mg / chewable tablet · 1 chewable tablet
৳1
Tab.
Marlox
Magaldrate
— Incepta Pharmaceuticals Ltd.
400mg / chewable tablet
Presentations
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Tablet: 1-3 tablets, after meals and at bed time or as directed by the physician.Syrup: 2 to 3 teaspoonful, 3 or 4 times daily, half to one hour after or before meal and at bedtime
Clinical notes
Applications:
- Peptic ulcer disease
Indication Notes:
Magaldrate is indicated to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastroesophageal reflux, hiatal hernia and flatulence. It is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Magaldrate may be given to children if necessary.
Avoid In:
N/A
Contraindication Notes:
Magaldrate is contraindicated in patients with known hypersensitivity to magnesium and aluminium. It is also contraindicated in patients with impaired renal function
Magaldrate is a hydroxymagnesium aluminate complex that is converted rapidly in gastric acid to Mg(OH)2 and Al(OH)3, which are absorbed poorly and thus provide a sustained antacid effect
Constipation and diarrhea may occur.
Pregnant women: Magaldrate may be used in pregnancy if indicated however one should avoid excessive dosage.Lactating mother: Magaldrate may pass into breast milk but has not been reported to cause problem in nursing babies.